Skip to content

SKINOVATION PHARMACEUTICAL INC

company.status.inactive

CIK 1118072fmd_1YT831GQ5MF2S1N36C7ZPZ3D3CFinance, Insurance and Real Estate · Blank ChecksTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2024, 58 periods

Latest annual · FY2023

Millions
Operating income
(0)
Net income
(0)

Latest quarter · Q3 FY2024

Millions
Operating income
(0)
Net income
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Net income, 5 yearsFY2018 to FY2023
n/m

SKINOVATION PHARMACEUTICAL INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2023FY2022ChangeSource
Operating income-$14,929-$14,05910-K 2024-04-15 · proof
Net income-$35,866-$33,74310-K 2024-04-15 · proof
Cash from operating activities-$8,929-$9,05910-K 2024-04-15 · proof
Total assets$16,234$163+9,859.5%10-K 2024-04-15 · proof
Total liabilities$463,435$411,498+12.6%10-K 2024-04-15 · proof
Cash and cash equivalents$16,234$163+9,859.5%10-K 2024-04-15 · proof
What was SKINOVATION PHARMACEUTICAL INC's operating income in fiscal 2023?
SKINOVATION PHARMACEUTICAL INC reported operating income of -$14,929 for fiscal 2023 (the year ended Dec 31, 2023), against -$14,059 the year before. Source: the 10-K filed with the SEC on Apr 15, 2024. SEC
What was SKINOVATION PHARMACEUTICAL INC's net income in fiscal 2023?
SKINOVATION PHARMACEUTICAL INC reported net income of -$35,866 for fiscal 2023 (the year ended Dec 31, 2023), against -$33,743 the year before. Source: the 10-K filed with the SEC on Apr 15, 2024. SEC
What was SKINOVATION PHARMACEUTICAL INC's cash from operating activities in fiscal 2023?
SKINOVATION PHARMACEUTICAL INC reported cash from operating activities of -$8,929 for fiscal 2023 (the year ended Dec 31, 2023), against -$9,059 the year before. Source: the 10-K filed with the SEC on Apr 15, 2024. SEC
What are SKINOVATION PHARMACEUTICAL INC's total assets?
As of Dec 31, 2023, SKINOVATION PHARMACEUTICAL INC reported total assets of $16,234, against $163 a year earlier (+9,859.5%). Source: the 10-K filed with the SEC on Apr 15, 2024. SEC
What are SKINOVATION PHARMACEUTICAL INC's total liabilities?
As of Dec 31, 2023, SKINOVATION PHARMACEUTICAL INC reported total liabilities of $463,435, against $411,498 a year earlier (+12.6%). Source: the 10-K filed with the SEC on Apr 15, 2024. SEC
What are SKINOVATION PHARMACEUTICAL INC's cash and cash equivalents?
As of Dec 31, 2023, SKINOVATION PHARMACEUTICAL INC reported cash and cash equivalents of $16,234, against $163 a year earlier (+9,859.5%). Source: the 10-K filed with the SEC on Apr 15, 2024. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1118072&period_type=annual&limit=5"

Information only, not investment advice.